– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million
(including a $553.7 million impairment of goodwill), and Adjusted
EBITDA of $146.7 million
– Identified potential medical cost savings of approximately
$6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1
2024
– CFO transition plan announced
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE:
MPLN), a leading value-added provider of data analytics and
technology-enabled end-to-end cost management, payment and revenue
integrity solutions to the U.S. healthcare industry, today reported
financial results for the second quarter ended June 30, 2024 and
updated its full-year 2024 guidance.
CEO Travis Dalton said, “During the second quarter, we
experienced growth in volumes of billed charges and identified
potential savings. Despite this, our revenues have continued to
track below our expectations, driven by volatility in our revenue
yield, and slower-than-anticipated sales of our new products and
services. As a result, we are reducing our expectations for the
second half of 2024.”
“Results matter, and these results are disappointing and
unacceptable. At the same time, as I look out to the medium and
longer-term horizons, I am even more confident in our business
today than when I first joined. We have a clear purpose to take
costs out of healthcare, a talented and dedicated workforce,
excellent analytics capabilities, underutilized technology assets,
and products that are relevant to our client’s needs,” said Mr.
Dalton. “Our strategic plan for our transformation into a data and
technology-driven company has come further into focus, and we have
been working to refine our operating model and get fit for growth,
so we can execute our strategy with discipline, predictability and
speed.”
“During the second quarter, we made considerable progress
aligning the organization for greater effectiveness, prioritizing
resource allocation, and sharpening the fundamentals of our
business execution,” Mr. Dalton continued. “Among other key
accomplishments, we expanded our sales force and improved our sales
processes, which will help us drive top-line growth with greater
predictability. Additionally, we implemented an integrated
stakeholder and policy engagement strategy that will educate
constituents about the value we provide to healthcare, protect our
reputation, and defend our business against false narratives and
misinformation. Further, we have continued to focus on the
alignment of our talent with a number of key hires, including two
senior leaders to head our corporate and government affairs
functions, a new sales leader to focus on provider markets, and, as
we announced this morning, our incoming CFO, Doug Garis.”
Mr. Dalton concluded, “I am confident these and other
enhancements to our foundation will, over time, enable us to run
the business with increased precision and discipline and will not
only get us back on track but ultimately drive our multi-year
transformation toward a world-class public company that delivers
performance excellence and sustainable growth.”
Business and Financial Highlights
- Revenues of $233.5 million for Q2 2024, a decrease of 1.9%,
compared to revenues of $238.0 million for Q2 2023.
- Net loss of $576.7 million for Q2 2024, compared to net loss of
$36.4 million for Q2 2023. The net loss was principally due to an
impairment charge of $553.7 million for goodwill.
- Adjusted EBITDA of $146.7 million for Q2 2024, compared to
Adjusted EBITDA of $152.7 million for Q2 2023.
- Net cash provided by operating activities of $18.5 million for
Q2 2024, compared to net cash provided by operating activities of
$7.7 million for Q2 2023.
- Free Cash Flow of $(7.0) million for Q2 2024, compared to Free
Cash Flow of $(24.3) million for Q2 2023.
- The Company ended Q2 2024 with $48.8 million of unrestricted
cash and cash equivalents on the balance sheet.
- The Company processed approximately $45.3 billion in claim
charges during Q2 2024, identifying potential medical cost savings
of approximately $6.2 billion.
- Based on the results of an impairment test as of June 30, 2024,
the estimated fair value of our goodwill asset was less than its
carrying value and as a result impairment charge of $553.7 million
for our goodwill was recorded.
2024 Financial Guidance1
The Company is updating its full-year 2024 guidance, as detailed
in the table below.
Financial Metric
Prior FY 2024 Guidance
Updated FY 2024 Guidance
Revenues
$1,000 million to $1,030 million
$935 million to $955 million
Adjusted EBITDA1
$630 million to $650 million
$580 million to $595 million
Interest expense
$320 million to $330 million
$320 million to $330 million
Cash flow from operations
$170 million to $200 million
$135 million to $150 million
Capital expenditures
$120 million to $130 million
$120 million to $130 million
Depreciation
$80 million to $90 million
$80 million to $90 million
Amortization of intangible assets
$345 million to $350 million
$345 million to $350 million
Effective tax rate
25% to 28%
25% to 28%
The Company anticipates Q3 2024 revenues between $230 million
and $245 million and Adjusted EBITDA1 between $140 million to $150
million.
Conference Call Information
The Company will host a conference call today, Thursday, August
1, 2024 at 9:30 a.m. U.S. Eastern Time (ET) to discuss its
financial results. To join the conference call, please pre-register
using the following link at least ten minutes before the call
begins:
https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913.
Upon registration, you will receive an email with the conference
dial-in details and a unique access code and pin.
A live webcast of the conference call can be accessed through
the Investor Relations section of the Company’s website at
investors.multiplan.com/events-and-presentations. Participants
should join the webcast ten minutes prior to the start of the
conference call. This earnings press release and a supplemental
slide deck will also be available on this section of the Company’s
website.
For those unable to listen to the live conference call, a replay
will be available approximately two hours after the call through
the archived webcast on the Investor Relations section of the
Company’s website.
About MultiPlan
MultiPlan is committed to bending the cost curve in healthcare
by delivering transparency, fairness, and affordability to the US
healthcare system. Our focus is on identifying medical savings,
helping to lower out-of-pocket costs, and reducing or eliminating
balance billing for healthcare consumers. Leveraging sophisticated
technology, data analytics, and a team rich with industry
experience, MultiPlan interprets customers’ needs and customizes
innovative solutions that combine its payment and revenue
integrity, network-based, data and decision science, and
analytics-based services. MultiPlan delivers value to more than 700
healthcare payors, over 100,000 employers, 60 million consumers,
and 1.4 million contracted providers. For more information, visit
multiplan.com.
Forward Looking Statements
This press release includes statements that express our
management’s opinions, expectations, beliefs, plans, objectives,
assumptions, or projections regarding future events or future
results and therefore are, or may be deemed to be, “forward-looking
statements”. These forward-looking statements can generally be
identified by the use of forward-looking terminology, including the
terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,”
“projects,” “forecasts,” “intends,” “plans,” “may,” “will,” or
“should” or, in each case, their negative or other variations or
comparable terminology. These forward-looking statements include
all matters that are not historical facts. They appear in a number
of places throughout this press release, including the discussion
of 2024 outlook and guidance, changes to our sales efforts, our
stakeholder engagement strategies, and other operational
enhancements, changes to our sales efforts, our stakeholder
engagement strategies, and other operational enhancements, and the
long-term prospects of the Company. Such forward-looking statements
are based on available current market information and management’s
expectations, beliefs and forecasts concerning future events
impacting the business. Although we believe that these
forward-looking statements are based on reasonable assumptions at
the time they are made, you should be aware that these
forward-looking statements involve a number of risks, uncertainties
(some of which are beyond our control) or other assumptions that
may cause actual results or performance to be materially different
from those expressed or implied by these forward-looking
statements. These factors include: loss of our customers,
particularly our largest customers; interruptions or security
breaches of our information technology systems and other
cybersecurity attacks; the impact of reduced claims volumes
resulting from a nationwide outage by a vendor used by our
customers; the ability to achieve the goals of our strategic plans
and recognize the anticipated strategic, operational, growth and
efficiency benefits when expected; our ability to enter new lines
of business and broaden the scope of our services; the loss of key
members of management team or inability to maintain sufficient
qualified personnel; our ability to continue to attract, motivate
and retain a large number of skilled employees, and adapt to the
effects of inflationary pressure on wages; trends in the U.S.
healthcare system, including recent trends of unknown duration of
reduced healthcare utilization and increased patient financial
responsibility for services; effects of competition; effects of
pricing pressure; our ability to identify, complete and
successfully integrate acquisitions; the inability of our customers
to pay for our services; changes in our industry and industry
standards and technology; our ability to protect proprietary
information, processes and applications; our ability to maintain
the licenses or right of use for the software we use; our inability
to expand our network infrastructure; our ability to obtain
additional financing; our ability to pay interest and principal on
our notes and other indebtedness; lowering or withdrawal of our
credit ratings; adverse outcomes related to litigation or
governmental proceedings; inability to preserve or increase our
market share or the size of our PPO networks; decreases in
discounts from providers; pressure to limit access to preferred
provider networks; the loss of our existing relationships with
providers; changes in our regulatory environment, including
healthcare law and regulations; the expansion of privacy and
security laws; heightened enforcement activity by government
agencies; the possibility that we may be adversely affected by
other political economic, business and/or competitive factors;
changes in accounting principles or the incurrence of impairment
charges our ability to remediate any material weaknesses or
maintain effective internal controls over financial reporting;
other factors disclosed in our Securities and Exchange Commission
(“SEC”) filings from time to time, including, without limitation,
those factors described in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2023 and our Quarterly Report for
the three months ended March 31, 2024; and other factors beyond our
control. Should one or more of these risks or uncertainties
materialize, or should any of the assumptions prove incorrect,
actual results may vary in material respects from those projected
in these forward-looking statements.
There can be no assurance that future developments affecting our
business will be those that we have anticipated. Forward-looking
statements speak only as of the date made.
We do not undertake any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
Non-GAAP Financial Measures
In addition to the financial measures prepared in accordance
with generally accepted accounting principles in the United States
(“GAAP”), this press release contains certain non-GAAP financial
measures, including EBITDA, Adjusted EBITDA, Free Cash Flow,
Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio. A
non-GAAP financial measure is generally defined as a numerical
measure of a company’s financial or operating performance that
excludes or includes amounts so as to be different than the most
directly comparable measure calculated and presented in accordance
with GAAP.
EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash
Flow and Adjusted Cash Conversion Ratio are supplemental measures
of MultiPlan’s performance that are not required by or presented in
accordance with GAAP. These measures are not measurements of our
financial or operating performance under GAAP, have limitations as
analytical tools and should not be considered in isolation or as an
alternative to net income, cash flows or any other measures of
performance prepared in accordance with GAAP.
EBITDA represents net income before interest expense, interest
income, income tax provision, depreciation, amortization of
intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA
as further adjusted by certain items as described in the table
below.
In addition, in evaluating EBITDA and Adjusted EBITDA you should
be aware that, in the future, we may incur expenses similar to the
adjustments in the presentation of EBITDA and Adjusted EBITDA. The
presentation of EBITDA and Adjusted EBITDA should not be construed
as an inference that our future results will be unaffected by
unusual or non-recurring items. The calculations of EBITDA and
Adjusted EBITDA may not be comparable to similarly titled measures
reported by other companies. Based on our industry and debt
financing experience, we believe that EBITDA and Adjusted EBITDA
are customarily used by investors, analysts and other interested
parties to provide useful information regarding a company’s ability
to service and/or incur indebtedness.
We also believe that Adjusted EBITDA is useful to investors and
analysts in assessing our operating performance during the periods
these charges were incurred on a consistent basis with the periods
during which these charges were not incurred. Both EBITDA and
Adjusted EBITDA have limitations as analytical tools, and you
should not consider either in isolation, or as a substitute for
analysis of our results as reported under GAAP. Some of the
limitations are:
- EBITDA and Adjusted EBITDA do not reflect changes in, or cash
requirements for, our working capital needs;
- EBITDA and Adjusted EBITDA do not reflect interest expense, or
the cash requirements necessary to service interest or principal
payments on our debt;
- EBITDA and Adjusted EBITDA do not reflect our tax expense or
the cash requirements to pay our taxes; and
- Although depreciation and amortization are non-cash charges,
the tangible assets being depreciated will often have to be
replaced in the future, and EBITDA and Adjusted EBITDA do not
reflect any cash requirements for such replacements.
MultiPlan’s presentation of Adjusted EBITDA should not be
construed as an inference that our future results and financial
position will be unaffected by unusual items.
Free Cash Flow is defined as net cash provided by operating
activities less capital expenditures, all as disclosed in the
Statements of Cash Flows. Unlevered Free Cash Flow is defined as
net cash provided by operating activities less capital
expenditures, plus cash interest paid, all as disclosed in the
Statements of Cash Flows. Free Cash Flow and Unlevered Free Cash
Flow are measures of our operational performance used by management
to evaluate our business after purchases of property and equipment
and, in the case of Unlevered Free Cash Flow, prior to the impact
of our capital structure. Free Cash Flow and Unlevered Free Cash
Flow should be considered in addition to, rather than as a
substitute for, consolidated net income as a measure of our
performance and net cash provided by operating activities as a
measure of our liquidity. Additionally, MultiPlan’s definitions of
Free Cash Flow and Unlevered Free Cash Flow are limited, in that
they do not represent residual cash flows available for
discretionary expenditures, due to the fact that the measures do
not deduct the payments required for debt service, in the case of
Unlevered Free Cash Flow, and other contractual obligations or
payments made for business acquisitions.
Adjusted Cash Conversion Ratio is defined as Unlevered Free Cash
Flow divided by Adjusted EBITDA. MultiPlan believes that the
presentation of the Adjusted Cash Conversion Ratio provides useful
information to investors because it is a financial performance
measure that shows how much of its Adjusted EBITDA MultiPlan
converts into Unlevered Free Cash Flow.
MULTIPLAN CORPORATION
Unaudited Condensed
Consolidated Balance Sheets
(in thousands, except share and
per share data)
June 30, 2024
December 31,
2023
Assets
Current assets:
Cash and cash equivalents
$
48,767
$
71,547
Restricted cash
10,402
9,947
Trade accounts receivable, net
81,420
76,558
Prepaid expenses
23,969
23,432
Prepaid taxes
—
1,364
Unbilled IDR fees
13,709
8,197
Other current assets, net
13,991
2,548
Total current assets
192,258
193,593
Property and equipment, net
286,777
267,429
Operating lease right-of-use assets
17,350
19,680
Goodwill
2,758,951
3,829,002
Other intangibles, net
2,458,565
2,633,207
Other assets, net
28,378
21,776
Total assets
$
5,742,279
$
6,964,687
Liabilities and Shareholders’
Equity
Current liabilities:
Accounts payable
$
22,287
$
19,590
Accrued interest
55,878
56,827
Accrued taxes
12,790
—
Operating lease obligation, short-term
4,818
4,792
Current portion of long-term debt
13,250
13,250
Accrued compensation
32,179
44,720
Accrued legal contingencies
23,123
12,123
Other accrued expenses
16,512
15,437
Total current liabilities
180,837
166,739
Long-term debt
4,510,765
4,532,733
Operating lease obligation, long-term
14,658
17,124
Private Placement Warrants and Unvested
Founder Shares
88
477
Deferred income taxes
428,060
521,707
Other liabilities
4,507
16,783
Total liabilities
5,138,915
5,255,563
Shareholders’ equity:
Shareholder interests
Preferred stock, $0.0000 par value —
10,000 shares authorized; no shares issued
—
—
Common stock, $0.0001 par value —
1,500,000,000 shares authorized; 675,438,163 and 667,808,296
issued; 645,723,791 and 648,319,379 shares outstanding
67
67
Additional paid-in capital
2,358,874
2,348,505
Accumulated other comprehensive loss
(1,121
)
(11,778
)
Retained deficit
(1,615,723
)
(499,307
)
Treasury stock — 29,714,372 and 19,488,917
shares
(138,733
)
(128,363
)
Total shareholders’ equity
603,364
1,709,124
Total liabilities and shareholders’
equity
$
5,742,279
$
6,964,687
MULTIPLAN CORPORATION
Unaudited Condensed
Consolidated Statements of Loss and Comprehensive Loss
(in thousands, except share and
per share data)
Three Months Ended June
30,
Six Months Ended June
30,
2024
2023
2024
2023
Revenues
$
233,476
$
237,991
$
467,984
$
474,585
Costs of services (exclusive of
depreciation and amortization of intangible assets shown below)
61,369
59,007
121,446
113,857
General and administrative expenses
34,551
39,750
69,408
71,217
Depreciation
21,811
18,901
42,800
37,107
Amortization of intangible assets
85,971
85,626
171,942
170,753
Loss on impairment of goodwill and
intangible assets
553,701
—
1,072,751
—
Total expenses
757,403
203,284
1,478,347
392,934
Operating (loss) income
(523,927
)
34,707
(1,010,363
)
81,651
Interest expense
81,129
82,475
163,327
165,903
Interest income
(551
)
(2,366
)
(1,477
)
(5,605
)
Gain on extinguishment of debt
—
—
(5,913
)
(36,778
)
(Gain) loss on change in fair value of
Private Placement Warrants and Unvested Founder Shares
(259
)
763
(389
)
2,394
Net loss before taxes
(604,246
)
(46,165
)
(1,165,911
)
(44,263
)
Benefit for income taxes
(27,519
)
(9,795
)
(49,495
)
(8,102
)
Net loss
$
(576,727
)
$
(36,370
)
$
(1,116,416
)
$
(36,161
)
Weighted average shares outstanding –
Basic
644,679,833
643,339,328
645,499,738
640,996,659
Weighted average shares outstanding –
Diluted
644,679,833
643,339,328
645,499,738
640,996,659
Net loss per share – Basic
$
(0.89
)
$
(0.06
)
$
(1.73
)
$
(0.06
)
Net loss per share – Diluted
$
(0.89
)
$
(0.06
)
$
(1.73
)
$
(0.06
)
Net loss
(576,727
)
(36,370
)
(1,116,416
)
(36,161
)
Other comprehensive income:
Change in unrealized gains (losses) on
interest rate swaps, net of tax
2,115
—
10,657
—
Comprehensive loss
$
(574,612
)
$
(36,370
)
$
(1,105,759
)
$
(36,161
)
MULTIPLAN CORPORATION
Unaudited Condensed
Consolidated Statements of Cash Flows
(in thousands)
Six Months Ended June
30,
2024
2023
Operating activities:
Net loss
$
(1,116,416
)
$
(36,161
)
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation
42,800
37,107
Amortization of intangible assets
171,942
170,753
Amortization of the right-of-use asset
2,330
2,865
Loss on impairment of goodwill and
intangible assets
1,072,751
—
Stock-based compensation
13,011
8,522
Deferred income taxes
(97,024
)
(47,167
)
Amortization of debt issuance costs and
discounts
5,818
5,106
Gain on extinguishment of debt
(5,913
)
(36,778
)
Loss on disposal of property and
equipment
130
243
(Gain) loss on change in fair value of
Private Placement Warrants and Unvested Founder Shares
(389
)
2,394
Changes in assets and liabilities:
Accounts receivable, net
(4,862
)
11,056
Prepaid expenses and other assets
(22,747
)
522
Prepaid taxes
1,364
(15,844
)
Operating lease obligation
(2,440
)
(3,513
)
Accounts payable, accrued interest,
accrued taxes, accrued expenses, legal contingencies and other
7,832
(27,205
)
Net cash provided by operating
activities
68,187
71,900
Investing activities:
Purchases of property and equipment
(55,989
)
(55,095
)
BST Acquisition, net of cash acquired
—
(141,294
)
Net cash used in investing activities
(55,989
)
(196,389
)
Financing activities:
Repurchase of 5.750% Notes
—
(99,954
)
Repayments of Term Loan B
(6,625
)
(6,625
)
Repurchase of Senior Convertible PIK
Notes
(14,886
)
—
Taxes paid on settlement of vested share
awards
(3,355
)
(457
)
Purchase of treasury stock
(10,370
)
(13,140
)
Proceeds from issuance of common stock
under Employee Stock Purchase Plan
713
—
Net cash used in financing activities
(34,523
)
(120,176
)
Net decrease in cash, cash equivalents and
restricted cash
(22,325
)
(244,665
)
Cash, cash equivalents and restricted cash
at beginning of period
81,494
340,559
Cash, cash equivalents and restricted cash
at end of period
$
59,169
$
95,894
Cash and cash equivalents
$
48,767
$
89,757
Restricted cash
10,402
6,137
Cash, cash equivalents and restricted cash
at end of period
$
59,169
$
95,894
Noncash investing and financing
activities:
Purchases of property and equipment not
yet paid
$
14,937
$
4,206
Supplemental disclosure of cash flow
information:
Cash paid during the period for:
Interest
$
(158,395
)
$
(161,484
)
Income taxes, net of refunds
$
(34,083
)
$
(55,533
)
MULTIPLAN CORPORATION
Calculation of EBITDA and
Adjusted EBITDA
(in thousands)
Three Months Ended June
30,
Six Months Ended June
30,
2024
2023
2024
2023
Net loss
$
(576,727
)
$
(36,370
)
$
(1,116,416
)
$
(36,161
)
Adjustments:
Interest expense
81,129
82,475
163,327
165,903
Interest income
(551
)
(2,366
)
(1,477
)
(5,605
)
Benefit for income taxes
(27,519
)
(9,795
)
(49,495
)
(8,102
)
Depreciation
21,811
18,901
42,800
37,107
Amortization of intangible assets
85,971
85,626
171,942
170,753
Non-income taxes
580
662
1,108
1,003
EBITDA
$
(415,306
)
$
139,133
$
(788,211
)
$
324,898
Adjustments:
Other expenses (income), net(1)
426
353
1,067
238
Integration expenses
791
788
1,144
1,831
Change in fair value of Private Placement
Warrants and unvested founder shares
(259
)
763
(389
)
2,394
Transaction-related expenses
—
6,818
—
7,836
Gain on extinguishment of debt
—
—
(5,913
)
(36,778
)
Loss on impairment of goodwill and
intangible assets
553,701
—
1,072,751
—
Stock-based compensation
7,317
4,827
13,011
8,522
Adjusted EBITDA
$
146,670
$
152,682
$
293,460
$
308,941
(1) "Other expenses (income),
net" represent miscellaneous non-recurring income, miscellaneous
non-recurring expense, gain or loss on disposal of assets,
impairment of other assets, gain or loss on disposal of leases, tax
penalties, and non-integration related severance costs.
Calculation of Unlevered Free
Cash Flow and Adjusted Cash Conversion Ratio
(in thousands)
Three Months Ended June
30,
Six Months Ended June
30,
2024
2023
2024
2023
Net cash provided by operating
activities
$
18,471
$
7,685
$
68,187
$
71,900
Purchases of property and equipment
(25,445
)
(31,994
)
(55,989
)
(55,095
)
Free Cash Flow
(6,974
)
(24,309
)
12,198
16,805
Interest paid
97,653
99,767
158,395
161,484
Unlevered Free Cash Flow
$
90,679
$
75,458
$
170,593
$
178,289
Adjusted EBITDA
$
146,670
$
152,682
$
293,460
$
308,941
Adjusted Cash Conversion Ratio
62
%
49
%
58
%
58
%
Net cash used in investing activities
$
(25,445
)
(173,288
)
$
(55,989
)
$
(196,389
)
Net cash used in financing activities
$
(3,035
)
(10,739
)
$
(34,523
)
$
(120,176
)
___________________________ 1 We have not reconciled the
forward-looking Adjusted EBITDA guidance included above to the most
directly comparable GAAP measure because this cannot be done
without unreasonable effort due to the variability and low
visibility with respect to certain costs, the most significant of
which are incentive compensation (including stock-based
compensation), transaction-related expenses, and certain fair value
measurements, which are potential adjustments to future earnings.
We expect the variability of these items to have a potentially
unpredictable, and a potentially significant, impact on our future
GAAP financial results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240801181080/en/
Investor Relations Luke Montgomery, CFA SVP, Finance
& Investor Relations MultiPlan 866-909-7427
investor@multiplan.com
Shawna Gasik AVP, Investor Relations MultiPlan 866-909-7427
investor@multiplan.com
Churchill Capital Corp III (NYSE:MPLN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Churchill Capital Corp III (NYSE:MPLN)
Historical Stock Chart
From Aug 2023 to Aug 2024